LIF transduces contradictory signals on capillary outgrowth through induction of stat3 and (P41/43)MAP kinase

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Paradis, H.
	Articles by Gendron, R. L.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Paradis, H.
	Articles by Gendron, R. L.

Adams, R. H., Wilkinson, G. A., Weiss, C., Diella, F., Gale, N.W., Deutsch, U., Risau, W. and Klein, R (1999). Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 1, 295-306.

Akeson, A. L., Wetzel, B., Thompson, F. Y., Brooks, S. K., Paradis, H., Gendron, R. L. and Greenberg J. M (2000). Embryonic vasculogenesis by endothelial precursor cells derived from lung mesenchyme. Dev. Dyn 217, 11-23.[Medline]

Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T. and Saltiel, A. R (1995). PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem 270, 27489-27494.[Abstract/Free Full Text]

Auernhammer, C.J., Bousquet, C. and Melmed, S (1999). Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc. Natl. Acad. Sci. USA 96, 6964-6969.[Abstract/Free Full Text]

Bonni, A., Sun, Y., Nadal-Vicens, M., Bhatt, A., Frank, D. A., Rozovsky,I., Stahl, N., Yancopoulos, G. D. and Greenberg, M. E (1997). Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278, 477-483.[Abstract/Free Full Text]

Bousquet, C., Susini, C. and Melmed, S (1999). Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. J. Clin. Invest 104, 1277-1285.[Medline]

Campbell, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B. and Mucke, L (1993). Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90, 10061-10065.[Abstract/Free Full Text]

Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D. Risau, W. and Nagy, A (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.[Medline]

Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R. Ciliberto, G., Moscinski, L., Fernandez-Luna, J. L., Nunez,G., Dalton, W. S and Jove, R (1999). Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10, 105-115.[Medline]

Chapman, R. S., Lourenco, P. C., Tonner, E., Flint, D. J., Selbert, S., Takeda, K., Akira, S., Clarke, A. R. and Watson, C. J (1999). Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 13, 2604-2616.[Abstract/Free Full Text]

Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G. and Levi, B. Z (1996). Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem 271, 736-741.[Abstract/Free Full Text]

D'Angelo, G., Struman, I., Martial, J. and Weiner, R. I (1995). Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc. Natl. Acad. Sci. USA 92, 6374-6378.[Abstract/Free Full Text]

Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J. and Saltiel, A. R (1995). A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92, 7686-7689.[Abstract/Free Full Text]

Dumont, D. J., Gradwohl, G., Fong, G.-H., Puri, M. C., Gertsenstein, M., Auerbach, A. and Breitman, M. L (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 9, 1897-1909.

Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M. and Alitalo, K (1998). Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282, 946-949.[Abstract/Free Full Text]

Duncan, S. A., Zhong, Z., Wen, Z. and Darnell, J. E. Jr (1997). STAT signaling is active during early mammalian development. Dev. Dyn 208, 190-198.[Medline]

Duval, D., Reinhardt, B., Kedinger, C. and Boeu, H (2000). Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF)-dependent embryonic stem cell survival. FASEB J 14, 1577-1584.[Abstract/Free Full Text]

Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., Miyazaki, T., Leonor, N., Taniguchi, T., Fujita, T., Kanakura, Y., Komiya, S. and Yoshimura, A (1997). A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387, 921-924.[Medline]

Ferrara, N., Winer, J. and Henzel, W. J (1992). Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor. Proc. Natl. Acad. Sci. USA 89, 698-702.[Abstract/Free Full Text]

Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J. and Moore, M. W (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.[Medline]

Flamme, I., Frolich, M. T. and Risau, W (1997). Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell. Physiol 172, 206-210.

Fong, G. H., Rossant, J., Gertsenstein, M. and Breitman, M. L (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70.[Medline]

Fox, P. L., Sa, G., Dobrowolski, S. F. and Stacey, D. W (1994). The regulation of endothelial cell motility by p21 ras. Oncogene 9, 3519-3526.[Medline]

Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K. and Hirano, T (1996). Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 5, 449-460.[Medline]

Fukada, T., Ohtani, T., Yoshida, Y., Shirogane, T., Nishid, K., Nakajima, K., Hibi, M. and Hirano, T (1998). STAT3 orchestrates contradictorysignals in cytokine-induced G1to S cell-cycle transition. EMBO J 17, 6670-6677.[Medline]

Garlanda, C., Parravicini, C., Sironi, M., De Rossi, M., Wainstok de Calmanovici, R., Carozzi, F., Bussolino, F., Colotta, F., Mantovani, A. and Vecchi, A (1994). Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: Implications for the pathogenesis of opportunistic vascular tumors. Proc. Natl. Acad. Sci. USA 91, 7291-7295.[Abstract/Free Full Text]

Gendron, R. L., Tsai, F. Y., Paradis, H. and Arceci, R. J (1996). Induction of embryonic vasculogenesis by bFGF and LIF in vitro and in vivo. Dev. Biol 177, 332-346.[Medline]

Giordano, V., De Falco, G., Chiari, R., Quinto, I., Pelicci, P.G., Bartholomew, L., Delmastro, P., Gadina, M. and Scala, G (1997). Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase. J. Immunol 158, 4097-4103.[Abstract]

Giraudo, E., Arese, M., Toniatti, C., Strasly, M., Primo, L., Mantovani, A., Ciliberto, G. and Bussolino, F (1996). IL-6 is an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells. J. Immunol 157, 2618-2623.[Abstract]

Hanahan, D (1997). Signaling vascular morphogenesis and maintenance. Science 277, 48-50.[Free Full Text]

Hatzopoulos, A. K., Folkman. J., Vasile, E., Eiselen, G. K. and Rosenberg, R. D (1998). Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 125, 1457-1468.[Abstract]

Heinrich, P. C., Behrmann, I., Muller-Newen, G., Schaper, F. and Graeve, L (1998). Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J 334, 297-314.

Henkemeyer, M., Rossi, D. J., Holmyard, D. P., Puri, M. C., Mbamalu, G., Harpal, K., Shih, T. S., Jacks, T., Pawson, T (1995). Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 377, 695-701.[Medline]

Holder, N. and Klein, R (1999). Eph receptors and ephrins: effectors of morphogenesis. Development 126, 2033-2044.[Abstract]

Horvath, C. M., Zilong, W. and Darnell, J. E (1995). A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 9, 984-994.[Abstract/Free Full Text]

Ihara, S., Nakajima, K., Fukada, T., Hibi, M., Nagata, S., Hirano, T. and Fukui, Y (1997). Dual control of neurite outgrowth by STAT3 and MAP kinase in PC12 cells stimulated with interleukin-6. EMBO J 16, 5345-5352.[Medline]

Ilan, N., Mahooti, S. and Madri, J. A (1998). Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J. Cell Sci 111, 3621-3631.[Abstract]

Klemke, R. L., Cai, S., Giannini, A. L., Gallagher, P. J., de Lanerolle, P. and Cheresh, D. A (1997). Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol 137, 481-492.[Abstract/Free Full Text]

Kim, H., Hawley, T. S., Hawley, R. G. and Baumann, H (1998). Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells. Mol. Cell. Biol 18, 1525-1533.[Abstract/Free Full Text]

Korpelainen, E. I., Karkkainen, M., Gunji, Y., Vikkula, M. and Alitalo, K (1999). Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Oncogene 18, 1-8.[Medline]

Kraling, B. M., Wiederschain, D. G., Boehm, T., Rehn, M., Mulliken, J. B. and Moses, M. A (1999). The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro. J. Cell Sci 112, 1599-1609.[Abstract]

Krebs, D. L. and Hilton, D. J (2000). SOCS: physiological suppressors of cytokine signaling. J. Cell Sci 113, 2813-2819.[Abstract]

Leconte, I., Fox, J. C., Baldwin, H. S., Buck, C. A. and Swain, J. L (1998). Adenoviral-mediated expression of antisense RNA to fibroblast growth factors disrupts murine vascular development. Dev. Dyn 213, 421-430.[Medline]

Li, J., Wei, Y. and Wagner, T.E (1999). In vitro endothelial differentiation of long-term cultured murine embryonic yolk sac cells induced by matrigel. Stem Cells 17, 72-81.[Abstract/Free Full Text]

Liu, X., Robinson, G. W., Wagner, K. U., Garrett, L., Wynshaw-Boris, A. and Hennighausen, L (1997). Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11, 179-186.[Abstract/Free Full Text]

Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., Daly, T. J, Davis, S., Sato, T. N. and Yancopoulos, G. D (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60.[Abstract/Free Full Text]

Maru, Y., Yamaguchi, S., Takahashi, T., Ueno, H. and Shibuya, M (1998). Virally activated Ras cooperates with integrin to induce tubulogenesis in sinusoidal endothelial cell lines. J. Cell. Physiol 176, 223-234.[Medline]

Masuhara, M., Sakamoto, H., Matsumoto, A., Suzuki, R., Yasukawa, H., Mitsui, K., Wakioka, T., Tanimura, S., Sasaki, A., Misawa, H., Yokouchi, M., Ohtsubo, M. and Yoshimura, A (1997). Cloning and characterization of novel CIS family genes. Biochem. Biophys. Res. Commun 239, 439-446.[Medline]

Minami, M., Inoue, M., Wei, S., Takeda, K., Matsumoto, M., Kishimoto, T. and Akira, S (1996). STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. USA 93, 3963-3966.[Abstract/Free Full Text]

Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto N., Kajita, T., Taga, T., Yoshizaki, K., Akira, S. and Kishimoto, T (1997). Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924-929.[Medline]

Naka, T., Matsumoto, T, Narazaki, M., Fujimoto, M., Morita, Y., Ohsawa, Y., Saito, H., Nagasawa, T., Uchiyama,Y. and Kishimoto, T (1998). Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA 95, 15577-15582.[Abstract/Free Full Text]

Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M. and Hirano, T (1996). A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 15, 3651-3658.[Medline]

Nicholson, S. E., Willson, T. A., Farley, A., Starr, R., Zhang, J. G., Baca, M., Alexander, W. S., Metcalf, D., Hilton, D. J. and Nicola, N. A (1999). Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J 18, 375-385.[Medline]

Oh, H., Fujio, Y., Kunisada, K., Hirota, H., Matsui, H., Kishimoto, T. and Yamauchi-Takihara, K (1998). Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes. J. Biol. Chem 273, 9703-9710.[Abstract/Free Full Text]

Paradis, H., Arceci, R. J., Adams, L. C. and Gendron, R. L (1998). Differentiation responses of embryonic endothelium to leukemia inhibitory factor. Exp. Cell Res 240, 7-15.[Medline]

Pepper, M. S., Ferrara, N., Orci, L. and Montesano, R (1995). Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. J. Cell Sci 108, 73-83.[Abstract]

Sadowski, H. B., Shuai, K., Darnell, J. E. Jr. and Gilman, M. Z (1993). A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261, 1739-1744.[Abstract/Free Full Text]

Sato, T. N., Tozawa, Y. Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y. Gendron-Maguire, M., Gridley, T. Wolburg, H. Risau, W. and Qin, Y (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74.[Medline]

Schiemann, W. P., Bartoe, J. L. and Nathanson, N. M (1997). Box 3-independent signaling mechanisms are involved in leukemia inhibitory factor receptor alpha-and gp130-mediated stimulation of mitogen-activated protein kinase. Evidence for participation of multiple signaling pathways which converge at Ras. J. Biol. Chem 272, 16631-16636.[Abstract/Free Full Text]

Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L. and Schuh, A. C (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.[Medline]

Skov, S., Nielsen, M., Bregenholt, S., Odum, N. and Claesson, M. H (1998). Activation of Stat3 is involved in the induction of apoptosis after ligation of major histocompatibility complex class I molecules on human Jurkat T cells. Blood 91, 3566-3573.[Abstract/Free Full Text]

Sosnowski, R. G., Feldman, S. and Feramisco, J. R (1993). Interference with endogenous ras function inhibits cellular responses to wounding. J. Cell Biol 121, 113-119.[Abstract/Free Full Text]

Stancato, L. F., Sakatsume, M., David, M., Dent, P., Dong, F., Petricoin, E. F., Krolewski, J. J., Silvennoinen, O., Saharinen, P., Pierce, J., Marshall, C. J., Sturgill, T., Finbloom, D. S. and Larner, A. C (1997). Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway. Mol. Cell. Biol 17, 3833-3840.[Abstract]

Starr, R., Willson, T. A., Viney, E. M., Murray, L. J., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A. and Hilton, D. J (1997). A family of cytokine-inducible inhibitors of signalling. Nature 387, 917-921.[Medline]

Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N. and Yancopoulos, G. D (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.[Medline]

Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T. and Akira, S (1997). Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94, 3801-3804.[Abstract/Free Full Text]

Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T. and Akira, S (1998). Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol 161, 4652-4560.[Abstract/Free Full Text]

Udy, G. B., Towers, R. P., Snell, R. G., Wilkins, R. J., Park, S. H., Ram, P. A., Waxman, D. J. and Davey, H. W (1997). Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 94, 7239-7244.[Abstract/Free Full Text]

Wang, S. J., Greer, P. and Auerbach, R (1996). Isolation and propagation of yolk-sac-derived endothelial cells from a hypervascular transgenic mouse expressing a gain-of-function fps/fes proto-oncogene. In Vitro Cell. Dev. Biol. Anim 32, 292-299.[Medline]

Ware, C. B., Horowitz, M. C., Renshaw, B. R., Hunt, J. S., Liggitt, D., Koblar, S. A., Gliniak, B. C., McKenna, H. J., Papayannopoulou, T., Thoma, B., Cheng, L., Donovan, P. J., Peschon, J. J., Bartlett, P. F., Willis, C. R., Wright, B. D., Carpenter, M. K., Davison, B. L. and Gearing, D. P (1995). Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121, 1283-1299.[Abstract]

Wegenka, U. M., buschmann, J., Luttiken, C. Heinrich, P. and Horn, F (1993). Acute-Phase Response Factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukine-6 at the posttranslational level. Mol. Cell. Biol 13, 276-288.[Abstract/Free Full Text]

Williams, R. L., Courtneige, S. A. and Wagner, E. F (1988). Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell 52, 121-131.[Medline]

Wojnowski, L., Zimmer, A. M., Beck, T. W., Hahn, H., Bernal, R., Rapp, U. R. and Zimmer, A (1997). Endothelial apoptosis in Braf-deficient mice. Nature Genetics 16, 293-297.[Medline]

Yamanaka, Y., Nakajima, K., Fukada, T., Hibi, M. and Hirano, T (1996). Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J 15, 1557-1565.[Medline]

Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., Hirabayashi, T., Yoneda, Y., Tanaka, K., Wang, W.-Z., Mori, C., Shiota, K., Yoshida, N. and Kishimoto, T (1996). Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA 93, 407-411.[Abstract/Free Full Text]

Zhang, J. G., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., Simpson, R. J., Moritz, R. L., Cary, D., Richardson, R., Hausmann, G., Kile, B. J., Kent, S. B., Alexander, W. S., Metcalf, D., Hilton, D. J., Nicola, N. A. and Baca, M (1999). The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. USA 96, 2071-2076.[Abstract/Free Full Text]

Zhong, Z., Wen, Z. and Darnell, J. E. Jr (1994). Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264, 95-98.[Abstract/Free Full Text]

This article has been cited by other articles:

H. Paradis, T. Islam, S. Tucker, L. Tao, S. Koubi, and R. L. Gendron
Tubedown associates with cortactin and controls permeability of retinal endothelial cells to albumin
J. Cell Sci., June 15, 2008; 121(12): 1965 - 1972.
[Abstract] [Full Text] [PDF]

D. Metcalf
The Unsolved Enigmas of Leukemia Inhibitory Factor
Stem Cells, January 1, 2003; 21(1): 5 - 14.
[Abstract] [Full Text] [PDF]

R. L. Gendron, W. V. Good, L. C. Adams, and H. Paradis
Suppressed Expression of Tubedown-1 in Retinal Neovascularization of Proliferative Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 3000 - 3007.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Paradis, H.

Articles by Gendron, R. L.

Search for Related Content

PubMed

PubMed Citation

Articles by Paradis, H.

Articles by Gendron, R. L.

				D. Metcalf The Unsolved Enigmas of Leukemia Inhibitory Factor Stem Cells, January 1, 2003; 21(1): 5 - 14. [Abstract] [Full Text] [PDF]

				R. L. Gendron, W. V. Good, L. C. Adams, and H. Paradis Suppressed Expression of Tubedown-1 in Retinal Neovascularization of Proliferative Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 3000 - 3007. [Abstract] [Full Text] [PDF]